Newsroom

Press Releases

ASCB opposes Trump Administration’s halt to fetal tissue research

June 6, 2019

The American Society for Cell Biology, a professional society of more than 8,000 basic biomedical researchers in all 50 states and 60 countries around the world, strongly opposes the decision by the Trump White House to halt the use of human fetal tissue for research in labs at the U.S. National Institutes of Health (NIH)…

Doorstep meeting explores cancer from genome instability to therapy

June 4, 2019

ASCB’s 2019 Doorstep meeting convenes Saturday, December 7, in Washington, DC, and focuses on “Cancer: from genome instability to therapy.”  This full-day meeting is being organized by Karlene Cimprich from Stanford University and David Pellman from Harvard Medical School and Dana Farber Cancer Institute. Limited to just 200 attendees, ASCB’s Doorstep seeks to provide an…

MBoC partners with cell journals in manuscript transfer system

May 16, 2019

Three cell biology journals now allow authors of manuscripts declined at one journal to transfer their submission seamlessly to another publication. Journal of Cell Biology (JCB), Journal of Cell Science (JCS), and Molecular Biology of the Cell (MBoC) have empowered researchers to transfer their rejected manuscript files, metadata, and  editor’s decision letter with reviewer comments…

Policy Statements

ASCB has a strong reputation as a leader in life science policy and as a “go-to” group for state, national, and international policymakers in need of critical information or advice on life science policy issues.

White Papers and Position Papers

One way ASCB educates government officials is through publication of Position Papers outlining ASCB’s position on critical science-related issues. ASCB Public Policy Committee Taskforces also produce White papers on specific topics of interest to the cell biology community.

ASCB Letters and Official Policy Comments

The ASCB also sends official letters in response to official requests for comment from agencies like the NIH and the NSF and to policymakers in Congress and federal agencies.

To read recent letters and policy comments by the ASCB, go to Letters and Official Policy Comments.

About ASCB

Erika Shugart, CEO
Andrew Murray, President

ASCB History

ASCB is an inclusive, international community of biologists studying the cell, the fundamental unit of life. We are dedicated to advancing scientific discovery, advocating sound research policies, improving education, promoting professional development, and increasing diversity in the scientific workforce. ASCB has 8,500 members and members in 57 countries around the world.